Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1998 Jan 20;952:576-81. doi: 10.1073/pnas.95.2.576.
Show Gene links
Show Anatomy links
Loss of cell adhesion in Xenopus laevis embryos mediated by the cytoplasmic domain of XLerk, an erythropoietin-producing hepatocellular ligand.
Jones TL
,
Chong LD
,
Kim J
,
Xu RH
,
Kung HF
,
Daar IO
.
???displayArticle.abstract???
The erythropoietin-producing hepatocellular (Eph) family of ligands and receptors has been implicated in the control of axon guidance and the segmental restriction of cells during embryonic development. In this report, we show that ectopic expression of XLerk, a Xenopus homologue of the murine Lerk-2 (ephrin-B1) transmembrane ligand, causes dissociation of Xenopus embryonic blastomeres by the mid-blastula transition. Moreover, a mutant that lacks the extracellular receptor binding domain can induce this phenotype. The carboxyl-terminal 19 amino acids of the cytoplasmic domain of XLerk are necessary but not sufficient to induce cellular dissociation. Basic fibroblast growth factor, but not activin, can rescue both the loss of cell adhesion and mesoderm induction in ectodermal explants expressing XLerk. Collectively, these results show that the cytoplasmic domain of XLerk has a signaling function that is important for cell adhesion, and fibroblast growth factor signaling modulates this function.
Figure 1
XLerk-induced blastomere dissociation in Xenopus embryos. Each blastomere of the 2-cell stage embryo was injected with 2.5 ng of either capped XLerk mRNA or XLerk1â215 mRNA, and development proceeded to the mid-blastula stage.
Figure 2
Western blot analysis of embryos injected with RNA encoding normal and mutant forms of XLerk. 2-Cell embryos were injected with 2.5 ng of RNA encoding all XLerk forms, except in the cases of XLerk215â327,215â307,215â287, where 0.5 ng of RNA were used. Extracts were prepared from stage 9 embryos, and three embryo equivalents were fractionated on 12% SDS-PAGE and then immunoblotted for the Flag epitope.
Figure 3
Localization of normal and mutant forms of XLerk by immunofluorescence. Embryos were injected with 2.5 ng of RNA encoding normal and mutant XLerk constructs. At stage 9, the embryos were fixed in Carnoyâs solution, embedded in parafin, and sectioned; then, immunofluorescence was performed using Flag M2 antibody and fluorescein-conjugated anti-mouse-Ig. These immunofluorescent images show that XLerk mutants retaining the transmembrane and cytoplasmic domains are localized to the membrane. (A) XLerk; (B) XLerk215â327; (C) XLerk1â308; (D) XLerk215â308. Note that an intact blastocoel is revealed in embryos expressing a C-terminal deletion of the last 19 amino acids in C. (E) Diffuse staining of XLerk250â327 that retains only the cytoplasmic domain. (F) Very low levels of diffuse staining of XLerk1â215, which just retains the ectodomain. (G) Membrane localization of XLerk1â250/307â327 and also an intact blastocoel. (H) Flag peptide competition control showing the specificity of the staining.
Figure 4
Scanning electron microscopy of XLerk-expressing embryos during the early blastula stage of development. 2-Cell stage embryos were injected with 2.5 ng of capped XLerk, XLerk1â308, or XLerk1â288 mRNA in each blastomere. Embryos were then fixed at stage 8 in 4% formaldehyde/1.25% glutaraldehyde and prepared for SEM.
Figure 5
(A) Western analysis of embryos overexpressing XLerk and C-cadherin. Embryos were either left alone or injected with 4 ng of XLerk RNA, or coinjected with 1 ng of C-cadherin RNA. At stage 9, extracts were prepared, and three embryo equivalents were fractionated by SDS-PAGE. Samples were immunoblotted with C-cadherin antibodies and a C-terminal XLerk antibody (cadherin appears as a doublet, perhaps representing the precursor and product forms). (B) C-Cadherin and β-catenin expression and association in XLerk-injected embryos. Embryos were either left alone or injected with 5 ng of XLerk RNA. Stage 9 embryos were harvested, and extracts were prepared. Three embryo equivalents were fractionated by SDS PAGE, and five embryo equivalents were subjected to immunoprecipitation analysis using β-catenin antibodies (β-Cat IP) and then fractionated by SDS-PAGE. Samples were immunoblotted with antibodies to β-catenin, C-cadherin, or phosphotyrosine.
Figure 6
(A) Morphological analysis of animal caps demonstrating the rescue of XLerk-injected embryos by bFGF. Animal caps were dissected at stage 8.5 and cultured at 23°C in 67% Leibovitzâs L-15 medium, 7 mM Trisâ HCl (pH 7.5), and 1 mg/ml gentamycin with or without 50 ng/ml Activin or 100 ng/ml bFGF. The animal caps were harvested at stage 26 as determined by uninjected embryos. These results are representative of four independent experiments. (B) Effect of XLerk on gene expression in the animal cap. Embryos were injected with either 5 ng of XLerk mRNA or β-galactosidase mRNA at the 2-cell stage. The animal caps were explanted at stage 8 and cultured in 50 ng/ml activin or 100 ng/ml bFGF until stage 11. Upon harvesting, RT-PCR analysis using primers specific for gsc, Xbra, and EF-1α was performed.
Aberle,
Assembly of the cadherin-catenin complex in vitro with recombinant proteins.
1994, Pubmed
Aberle,
Assembly of the cadherin-catenin complex in vitro with recombinant proteins.
1994,
Pubmed
Arends,
Apoptosis: mechanisms and roles in pathology.
1991,
Pubmed
Beckmann,
Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors.
1994,
Pubmed
Blumberg,
Organizer-specific homeobox genes in Xenopus laevis embryos.
1991,
Pubmed
,
Xenbase
Böhme,
Cell-cell adhesion mediated by binding of membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity.
1996,
Pubmed
Brambilla,
Similarities and differences in the way transmembrane-type ligands interact with the Elk subclass of Eph receptors.
1996,
Pubmed
Brieher,
Regulation of C-cadherin function during activin induced morphogenesis of Xenopus animal caps.
1994,
Pubmed
,
Xenbase
Brückner,
Tyrosine phosphorylation of transmembrane ligands for Eph receptors.
1997,
Pubmed
Cheng,
Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map.
1995,
Pubmed
Doherty,
CAM-FGF Receptor Interactions: A Model for Axonal Growth.
1996,
Pubmed
Doherty,
CAM-FGF receptor interactions: a model for axonal growth.
1997,
Pubmed
Drescher,
In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases.
1995,
Pubmed
Easty,
Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
1995,
Pubmed
Gale,
Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis.
1996,
Pubmed
Gao,
Regulation of topographic projection in the brain: Elf-1 in the hippocamposeptal system.
1996,
Pubmed
Green,
Slow emergence of a multithreshold response to activin requires cell-contact-dependent sharpening but not prepattern.
1994,
Pubmed
,
Xenbase
Heasman,
Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos.
1994,
Pubmed
,
Xenbase
Hemmati-Brivanlou,
Inhibition of activin receptor signaling promotes neuralization in Xenopus.
1994,
Pubmed
,
Xenbase
Henkemeyer,
Nuk controls pathfinding of commissural axons in the mammalian central nervous system.
1996,
Pubmed
Hirai,
A novel putative tyrosine kinase receptor encoded by the eph gene.
1987,
Pubmed
Holash,
Polarized expression of the receptor protein tyrosine kinase Cek5 in the developing avian visual system.
1995,
Pubmed
Holland,
Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.
1996,
Pubmed
Hunter,
Oncoprotein networks.
1997,
Pubmed
Jones,
Expression of an amphibian homolog of the Eph family of receptor tyrosine kinases is developmentally regulated.
1995,
Pubmed
,
Xenbase
Jones,
Identification of XLerk, an Eph family ligand regulated during mesoderm induction and neurogenesis in Xenopus laevis.
1997,
Pubmed
,
Xenbase
Kenny,
The receptor tyrosine kinase QEK5 mRNA is expressed in a gradient within the neural retina and the tectum.
1995,
Pubmed
Kintner,
Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain.
1992,
Pubmed
,
Xenbase
Lemaire,
A role for cytoplasmic determinants in mesoderm patterning: cell-autonomous activation of the goosecoid and Xwnt-8 genes along the dorsoventral axis of early Xenopus embryos.
1994,
Pubmed
,
Xenbase
Maru,
Overexpression confers an oncogenic potential upon the eph gene.
1990,
Pubmed
Mason,
Cell signalling. Do adhesion molecules signal via FGF receptors?
1994,
Pubmed
Nagafuchi,
The roles of catenins in the cadherin-mediated cell adhesion: functional analysis of E-cadherin-alpha catenin fusion molecules.
1994,
Pubmed
Nakamoto,
Topographically specific effects of ELF-1 on retinal axon guidance in vitro and retinal axon mapping in vivo.
1996,
Pubmed
Newport,
A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage.
1982,
Pubmed
,
Xenbase
Orioli,
Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation.
1996,
Pubmed
Saffell,
Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs.
1997,
Pubmed
Scales,
Novel members of the eph receptor tyrosine kinase subfamily expressed during Xenopus development.
1995,
Pubmed
,
Xenbase
Sible,
Zygotic transcription is required to block a maternal program of apoptosis in Xenopus embryos.
1997,
Pubmed
,
Xenbase
Smith,
Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center.
1991,
Pubmed
,
Xenbase
Smith,
The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells.
1997,
Pubmed
,
Xenbase
Song,
Spatial and temporal expression of basic fibroblast growth factor (FGF-2) mRNA and protein in early Xenopus development.
1994,
Pubmed
,
Xenbase
Stack,
Developmentally regulated activation of apoptosis early in Xenopus gastrulation results in cyclin A degradation during interphase of the cell cycle.
1997,
Pubmed
,
Xenbase
Symes,
Mesoderm induction in Xenopus laevis: responding cells must be in contact for mesoderm formation but suppression of epidermal differentiation can occur in single cells.
1988,
Pubmed
,
Xenbase
Tuzi,
eph, the largest known family of putative growth factor receptors.
1994,
Pubmed
Wang,
Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth.
1997,
Pubmed
Winklbauer,
Motile behavior and protrusive activity of migratory mesoderm cells from the Xenopus gastrula.
1992,
Pubmed
,
Xenbase
Winning,
Disruption of cell adhesion in Xenopus embryos by Pagliaccio, an Eph-class receptor tyrosine kinase.
1996,
Pubmed
,
Xenbase
Winslow,
Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation.
1995,
Pubmed
Wyllie,
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.
1980,
Pubmed
Xu,
Function of the Eph-related kinase rtk1 in patterning of the zebrafish forebrain.
1996,
Pubmed
Xu,
Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain.
1995,
Pubmed
,
Xenbase